Hepcvir L Tablet contains a fixed-dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg. It is an oral antiviral medicine used for the treatment of certain cases of chronic hepatitis C virus (HCV) infection. Hepatitis C is a viral infection that primarily affects the liver, and modern direct-acting antiviral (DAA) medicines can cure most people when appropriately selected and used under medical supervision.
What Is Hepcvir L Tablet?
Hepcvir L combines two antiviral medicines:
- Ledipasvir – 90 mg
- Sofosbuvir – 400 mg
The combination works against different proteins involved in HCV replication. Ledipasvir inhibits the HCV NS5A protein, while sofosbuvir acts on the HCV NS5B RNA-dependent RNA polymerase.
The 90 mg/400 mg combination is also an established strength for ledipasvir/sofosbuvir therapy. The WHO Model List of Essential Medicines has included this combination at 90 mg/400 mg.
Hepcvir L Uses
Hepcvir L is used for chronic hepatitis C infection, with the exact suitability depending on factors such as HCV genotype, liver condition, previous treatment, other medicines, and whether cirrhosis or other complications are present.
Ledipasvir/sofosbuvir products have established use in specific HCV populations. Current prescribing information for ledipasvir/sofosbuvir describes use in adults and certain pediatric patients, with treatment recommendations varying according to genotype and clinical circumstances.
Because hepatitis C treatment should be individualized, patients should undergo appropriate HCV testing and medical evaluation before starting therapy.
Hepcvir L Strength and Composition
Hepcvir L 90 mg/400 mg Tablet contains:
| Active ingredient | Strength |
|---|---|
| Ledipasvir | 90 mg |
| Sofosbuvir | 400 mg |
A commonly referenced adult ledipasvir/sofosbuvir regimen uses one 90 mg/400 mg tablet once daily, but the appropriate treatment duration and regimen should be determined by a qualified healthcare professional.
Hepcvir L Price in India
The Hepcvir L price in India can vary depending on the supplier, pharmacy, location, taxes, pack size, and availability. Online Indian listings have recently shown prices around ₹20,000+ for a 28-tablet pack, although displayed prices can change and should be verified before purchase.
For current pricing, bulk requirements, or export enquiries, buyers should request a quotation based on the required quantity and destination.
Hepcvir L Availability
Hepcvir L availability may vary between pharmacies and suppliers. Current online listings have shown the product as temporarily unavailable in some locations, demonstrating why buyers should confirm stock before placing an order.
For pharmaceutical procurement, availability should also be checked against the import and regulatory requirements of the destination country.
Important Safety Information
Hepcvir L is a prescription medicine and should be used only under appropriate medical supervision. Patients should tell their doctor about all medicines and supplements they take because drug interactions can affect treatment. Current prescribing information also carries an important warning concerning hepatitis B reactivation in patients who have HCV/HBV coinfection.
Frequently Asked Questions
What is Hepcvir L used for?
Hepcvir L is a combination of ledipasvir and sofosbuvir used for treating certain chronic hepatitis C infections.
What is the strength of Hepcvir L?
Hepcvir L contains Ledipasvir 90 mg + Sofosbuvir 400 mg per tablet.
How much does Hepcvir L cost in India?
The price can vary by pharmacy, location, pack size, and availability. Current online listings should be checked for the latest price.
Is Hepcvir L available in India?
Availability can change by supplier and location. Buyers should confirm current stock and prescription requirements before purchasing.
Can Hepcvir L be purchased for export?
Pharmaceutical exports are subject to the applicable regulations of the exporting and importing countries. Buyers should confirm destination-country requirements before arranging supply.
Conclusion
Hepcvir L 90 mg/400 mg combines Ledipasvir and Sofosbuvir, two direct-acting antiviral medicines used in the management of certain chronic HCV infections. Its strength, price, availability, and suitability depend on the patient's clinical requirements and the local market. Always obtain professional medical advice before starting hepatitis C treatment and verify current product availability with a legitimate pharmaceutical supplier.